{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:58Z","timestamp":1789824898491,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE785\/2-2"],"award-info":[{"award-number":["FE785\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE785\/4-1"],"award-info":[{"award-number":["FE785\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010121","name":"Sonnenfeld Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010121","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.antiviral.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T21:26:07Z","timestamp":1432848367000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir"],"prefix":"10.1016","volume":"120","author":[{"given":"Tanja","family":"Pozzuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"R\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kurreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.05.010_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-61779-037-9_20","article-title":"Intranasal delivery of antiviral siRNA","volume":"721","author":"Barik","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.antiviral.2015.05.010_b0015","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00193-07","article-title":"High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein","volume":"81","author":"Catanese","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0020","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.74.10.4672-4678.2000","article-title":"Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo","volume":"74","author":"Christiansen","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0025","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00705-007-0951-z","article-title":"Silencing E1A mRNA by RNA interference inhibits adenovirus replication","volume":"152","author":"Chung","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","article-title":"Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)","volume":"77","author":"DeVincenzo","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2010.08.002","article-title":"Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions","volume":"88","author":"Eckstein","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.05.010_b0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00109-008-0363-x","article-title":"Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy","volume":"86","author":"Fechner","year":"2008","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.antiviral.2015.05.010_b0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1743-422X-8-249","article-title":"Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin","volume":"8","author":"Flusin","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2015.05.010_b0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1525-0016(03)00244-2","article-title":"Small interfering RNA inhibits hepatitis B virus replication in mice","volume":"8","author":"Giladi","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2015.05.010_b0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.1998.9102","article-title":"Human cells arrest in S phase in response to adenovirus 12 E1A","volume":"244","author":"Grand","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.010_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4161\/adna.1.1.11981","article-title":"Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAs","volume":"1","author":"Hean","year":"2010","journal-title":"Artif. DNA, PNA & XNA"},{"key":"10.1016\/j.antiviral.2015.05.010_b0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0042-6822(90)90134-D","article-title":"Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication","volume":"179","author":"Hitt","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.010_b0075","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/320146","article-title":"Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis","volume":"32","author":"Hong","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.mph.0000153958.95486.6f","article-title":"Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia","volume":"27","author":"Hough","year":"2005","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2012.10.008","article-title":"An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs","volume":"97","author":"Ibrisimovic","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.transproceed.2012.06.059","article-title":"Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report","volume":"45","author":"Kerensky","year":"2013","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.antiviral.2015.05.010_b0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2012.03.011","article-title":"Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery","volume":"94","author":"Kneidinger","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0105","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1093\/nar\/gkl589","article-title":"Competition for RISC binding predicts in vitro potency of siRNA","volume":"34","author":"Koller","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/oli.2006.0065","article-title":"Insights into effective RNAi gained from large-scale siRNA validation screening","volume":"17","author":"Krueger","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.antiviral.2015.05.010_b0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12013-014-9846-2","article-title":"SiRNA combinations mediate greater suppression of hepatitis B virus replication in mice","volume":"69","author":"Li","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2015.05.010_b0120","first-page":"CD008439","article-title":"Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection","volume":"7","author":"Li","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2015.05.010_b0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1196\/annals.1348.006","article-title":"RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy","volume":"1082","author":"Li","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2015.05.010_b0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cardiores.2006.05.016","article-title":"Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis","volume":"71","author":"Lim","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"63\u201366","key":"10.1016\/j.antiviral.2015.05.010_b0135","first-page":"e65","article-title":"Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers","volume":"146","author":"Ma","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.05.010_b0140","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.bmc.2013.04.073","article-title":"Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2\u2032-O-guanidinopropyl modified siRNAs","volume":"21","author":"Marimani","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.05.010_b0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrg908","article-title":"Gene silencing in mammals by small interfering RNAs","volume":"3","author":"McManus","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2015.05.010_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":"Cidofovir-induced end-stage renal failure","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.antiviral.2015.05.010_b0155","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.7314\/APJCP.2013.14.12.7045","article-title":"RNAi and miRNA in viral infections and cancers","volume":"14","author":"Mollaie","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.antiviral.2015.05.010_b0160","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0165","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/o88-068","article-title":"Transactivation by the adenovirus E1A gene","volume":"66","author":"Nevins","year":"1988","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0170","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0175","doi-asserted-by":"crossref","first-page":"13409","DOI":"10.1128\/JVI.00621-11","article-title":"Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line","volume":"85","author":"Pinkert","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0180","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1161\/CIRCULATIONAHA.108.845339","article-title":"Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor","volume":"120","author":"Pinkert","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2015.05.010_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvq056","article-title":"Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure","volume":"86","author":"Poller","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0190","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.1207","article-title":"Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice","volume":"10","author":"Rauschhuber","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.antiviral.2015.05.010_b9000","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2015.19","article-title":"Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice","author":"R\u00f6ger","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2015.05.010_b0200","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0205","doi-asserted-by":"crossref","first-page":"13448","DOI":"10.1128\/JVI.77.24.13448-13454.2003","article-title":"Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5","volume":"77","author":"Salone","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2014.01.025","article-title":"Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo","volume":"454\u2013455","author":"Shen","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.05.010_b0215","first-page":"195","article-title":"Adenovirus","volume":"343","author":"Smith","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0220","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/infdis\/jiu504","article-title":"Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice","volume":"211","author":"Stein","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0225","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.21120","article-title":"Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia","volume":"50","author":"Steiner","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.antiviral.2015.05.010_b0230","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/mt.2012.119","article-title":"Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model","volume":"20","author":"Suhy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2015.05.010_b0235","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: a multiple shRNA approach","volume":"14","author":"ter Brake","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2015.05.010_b0245","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1128\/AAC.01626-08","article-title":"Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir","volume":"53","author":"Vigne","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.05.010_b0250","first-page":"463569","article-title":"Fatal fulminant hepatic failure from adenovirus in allogeneic bone marrow transplant patients","volume":"2012","author":"Vyas","year":"2012","journal-title":"Case Rep. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1473-3099(03)00515-2","article-title":"Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients","volume":"3","author":"Walls","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.05.010_b0260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.yjmcc.2004.06.009","article-title":"Phospholamban ablation by RNA interference increases Ca2+ uptake into rat cardiac myocyte sarcoplasmic reticulum","volume":"37","author":"Watanabe","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0265","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/srep04750","article-title":"In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus","volume":"4","author":"Watanabe","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2015.05.010_b0270","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.antiviral.2009.07.002","article-title":"Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3","volume":"83","author":"Werk","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.05.010_b0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.127.1.257","article-title":"Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization","volume":"127","author":"Wickham","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2015.05.010_b0285","doi-asserted-by":"crossref","first-page":"176418","DOI":"10.1155\/2013\/176418","article-title":"Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation","volume":"2013","author":"Wy Ip","year":"2013","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.antiviral.2015.05.010_b0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10529-011-0761-y","article-title":"Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an HCV-infected cell model","volume":"34","author":"Xing","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.antiviral.2015.05.010_b0295","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/382598","article-title":"Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice","volume":"189","author":"Yanagawa","year":"2004","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:33:22Z","timestamp":1599064402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":60,"alternative-id":["S0166354215001308"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}